Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366886 · ClinicalTrials.gov registry record
Patients With NMDA Biomarker Data Following Cardiac Surgery
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 22
- Enrollment target
NCT00366886: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00366886 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00366886 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this current retrospective study is to perform follow-up analysis on the 22 children from the study # 621-2004 It is important to examine whether an elevated biomarker of brain ischemia before and/or following cardiac surgery has any clinical or functional implications as the child ages.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Est. Completion | 2006-07 |
Why NCT00366886 stopped before completion
NCT00366886 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00366886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00366886 about?
NCT00366886 is a clinical study titled "Patients With NMDA Biomarker Data Following Cardiac Surgery". The purpose of this current retrospective study is to perform follow-up analysis on the 22 children from the study # 621-2004 It is important to examine whether an elevated biomarker of brain ischemia before and/or following cardiac surgery has any clinical or functional implications as the child ag...
What is the current status of trial NCT00366886?
This trial is currently terminated. The enrollment target is 22 participants. Estimated completion is 2006-07.
Who is sponsoring clinical trial NCT00366886?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma